IL33 and colon carcinoma: In mouse models of colon carcinoma, endogenous IL-33 overcame the pro-tumorigenic effect of Treg by increasing IFN-γ production of tumor-infiltrating CD4+ and CD8+ T cells, as well as the accumulation of these infiltrating CD8+ T cells, exerting their anti-tumor effect [164].